We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$26B
AUM Growth
+$2.52B
Cap. Flow
+$734M
Cap. Flow %
2.83%
Top 10 Hldgs %
21.08%
Holding
3,430
New
246
Increased
1,548
Reduced
1,426
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 10.99%
2 Financials 5.01%
3 Consumer Discretionary 4.04%
4 Healthcare 3.7%
5 Industrials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOUG icon
3251
Douglas Elliman
DOUG
$184M
$27K ﹤0.01%
17,295
-6,080
-26% -$12.4K
TE
3252
T1 Energy
TE
$1.37B
$27K ﹤0.01%
16,201
+17
+0.1% +$27
ACXP icon
3253
Acurx Pharmaceuticals
ACXP
$6.62M
$25K ﹤0.01%
+500
New +$32.5K
SBEV icon
3254
Splash Beverage Group
SBEV
$2.58M
$24K ﹤0.01%
325
AHT
3255
Ashford Hospitality Trust
AHT
$19.8M
$23K ﹤0.01%
1,705
PLBY icon
3256
Playboy Inc
PLBY
$149M
$23K ﹤0.01%
21,849
+27
+0.1% +$29
DHY
3257
Credit Suisse High Yield Credit Fund
DHY
$239M
$22K ﹤0.01%
+10,999
New +$21.9K
EOSE icon
3258
Eos Energy Enterprises
EOSE
$1.54B
$22K ﹤0.01%
21,200
-5,100
-19% -$5.18K
PSNY icon
3259
Polestar Automotive Holding UK
PSNY
$1.99B
$22K ﹤0.01%
485
-14
-3% -$758
SLQT icon
3260
SelectQuote
SLQT
$124M
$21K ﹤0.01%
10,483
-509
-5% -$761
AMRN
3261
Amarin Corp
AMRN
$297M
$19K ﹤0.01%
1,057
+77
+8% +$1.64K
GSAT icon
3262
Globalstar
GSAT
$10.8B
$19K ﹤0.01%
853
+40
+5% +$969
VERU icon
3263
Veru
VERU
$46.7M
$19K ﹤0.01%
+2,648
New +$14.1K
GOSS icon
3264
Gossamer Bio
GOSS
$86.8M
$18K ﹤0.01%
+15,000
New +$16.5K
SMR.WS
3265
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
$18K ﹤0.01%
22,500
+10,000
+80% +$4.39K
TCS
3266
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$18K ﹤0.01%
+1,037
New +$22.4K
CLSD
3267
DELISTED
Clearside Biomedical
CLSD
$17K ﹤0.01%
733
+33
+5% +$711
ZSQR
3268
Z Squared Inc
ZSQR
$205M
$17K ﹤0.01%
2,807
SGMO
3269
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$17K ﹤0.01%
25,290
-5,284
-17% -$3.83K
REFR icon
3270
Research Frontiers
REFR
$16.8M
$16K ﹤0.01%
+12,000
New +$13.2K
RENT
3271
Rent the Runway
RENT
$119M
$15K ﹤0.01%
2,101
+350
+20% +$3.33K
ORGS
3272
DELISTED
Orgenesis Inc. Common Stock
ORGS
$15K ﹤0.01%
1,833
AGEN
3273
Agenus
AGEN
$311M
$14K ﹤0.01%
1,219
-201
-14% -$2.67K
VISN
3274
Vistance Networks Inc
VISN
$2.67B
$14K ﹤0.01%
10,589
-3
-0% -$6
RJET
3275
Republic Airways Holdings
RJET
$962M
$14K ﹤0.01%
1,066
-33
-3% -$450

Similar funds

Cambridge Investment Research Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Cambridge Investment Research Advisors held 3,430 positions worth $26B, up 11% from $23.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q1 2024 filing shows 246 new, 1,548 increased, 1,426 reduced and 128 closed positions. Its largest new stake was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M. The largest sale was Apple, an estimated $25M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q1 2024 buy was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M.
  • Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q1 2024, an estimated $25.4M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $25M.
  • Cambridge Investment Research Advisors fully exited iMGP RBA Responsible Global Allocation ETF in Q1 2024, selling an estimated $3.97M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $26B portfolio in Q1 2024.
  • Cambridge Investment Research Advisors opened 246 new positions and closed 128 in Q1 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $26B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.